These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 19769558)
21. [Monitoring of the insulin treated diabetic]. Soltani D; Perlemuter L Presse Med; 1998 Jul 4-11; 27(24):1251-4. PubMed ID: 9767789 [No Abstract] [Full Text] [Related]
22. Predictors of glycaemic control and hypoglycaemia in children and adolescents with type 1 diabetes from NSW and the ACT. Craig ME; Handelsman P; Donaghue KC; Chan A; Blades B; Laina R; Bradford D; Middlehurst A; Ambler G; Verge CF; Crock P; Moore P; Silink M; Med J Aust; 2002 Sep; 177(5):235-8. PubMed ID: 12197816 [TBL] [Abstract][Full Text] [Related]
23. Hypoglycaemia: an overview. Graveling AJ; Frier BM Prim Care Diabetes; 2009 Aug; 3(3):131-9. PubMed ID: 19782016 [TBL] [Abstract][Full Text] [Related]
24. Insulin lispro protamine suspension in intensive insulin treatment: an Italian observational study. Citro G; Lorusso B; Rossi A; Romaniello M; Gentilella R; Cremasco F Curr Med Res Opin; 2009 Sep; 25(9):2259-65. PubMed ID: 19630489 [TBL] [Abstract][Full Text] [Related]
25. Diabetes Mellitus in German Primary Care: quality of glycaemic control and subpopulations not well controlled - results of the DETECT study. Huppertz E; Pieper L; Klotsche J; Stridde E; Pittrow D; Böhler S; Lehnert H Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):6-14. PubMed ID: 18465681 [TBL] [Abstract][Full Text] [Related]
26. Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy. Fulcher GR; Gilbert RE; Yue DK Intern Med J; 2005 Sep; 35(9):536-42. PubMed ID: 16105155 [TBL] [Abstract][Full Text] [Related]
27. Psychosocial factors associated with use of continuous glucose monitoring. Ritholz MD; Atakov-Castillo A; Beste M; Beverly EA; Leighton A; Weinger K; Wolpert H Diabet Med; 2010 Sep; 27(9):1060-5. PubMed ID: 20722681 [TBL] [Abstract][Full Text] [Related]
28. Glycated albumin but not HbA1c reflects glycaemic control in patients with neonatal diabetes mellitus. Suzuki S; Koga M; Amamiya S; Nakao A; Wada K; Okuhara K; Hayano S; Sarhat AR; Takahashi H; Matsuo K; Tanahashi Y; Fujieda K Diabetologia; 2011 Sep; 54(9):2247-53. PubMed ID: 21644010 [TBL] [Abstract][Full Text] [Related]
29. The "glucose pentagon": assessing glycemic control of patients with diabetes mellitus by a model integrating different parameters from glucose profiles. Thomas A; Schönauer M; Achermann F; Schnell O; Hanefeld M; Ziegelasch HJ; Mastrototaro J; Heinemann L Diabetes Technol Ther; 2009 Jun; 11(6):399-409. PubMed ID: 19459770 [TBL] [Abstract][Full Text] [Related]
30. Targets and tactics: the relative importance of HbA, fasting and postprandial plasma glucose levels to glycaemic control in type 2 diabetes. Woo V; Shestakova MV; Ørskov C; Ceriello A Int J Clin Pract; 2008 Dec; 62(12):1935-42. PubMed ID: 19166440 [TBL] [Abstract][Full Text] [Related]
31. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ismail-Beigi F; Moghissi E; Tiktin M; Hirsch IB; Inzucchi SE; Genuth S Ann Intern Med; 2011 Apr; 154(8):554-9. PubMed ID: 21502652 [TBL] [Abstract][Full Text] [Related]
32. Initial treatment with fixed-dose combination rosiglitazone/glimepiride in patients with previously untreated type 2 diabetes. Chou HS; Palmer JP; Jones AR; Waterhouse B; Ferreira-Cornwell C; Krebs J; Goldstein BJ Diabetes Obes Metab; 2008 Aug; 10(8):626-37. PubMed ID: 17645558 [TBL] [Abstract][Full Text] [Related]
33. Glycaemic variability in diabetes: clinical and therapeutic implications. Ceriello A; Monnier L; Owens D Lancet Diabetes Endocrinol; 2019 Mar; 7(3):221-230. PubMed ID: 30115599 [TBL] [Abstract][Full Text] [Related]
34. Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: data from the Adult Diabetes Control and Management. Sazlina SG; Mastura I; Ahmad Z; Cheong AT; Adam BM; Jamaiyah H; Lee PY; Syed-Alwi SA; Chew BH; Sriwahyu T Geriatr Gerontol Int; 2014 Jan; 14(1):130-7. PubMed ID: 23581598 [TBL] [Abstract][Full Text] [Related]
35. Frequency of glycated hemoglobin monitoring was inversely associated with glycemic control of patients with Type 2 diabetes mellitus. Fu C; Ji L; Wang W; Luan R; Chen W; Zhan S; Xu B J Endocrinol Invest; 2012 Mar; 35(3):269-73. PubMed ID: 21606668 [TBL] [Abstract][Full Text] [Related]
36. Patterns of glycaemic control in Australian primary care (NEFRON 8). Macisaac RJ; Jerums G; Weekes AJ; Thomas MC Intern Med J; 2009 Aug; 39(8):512-8. PubMed ID: 19220533 [TBL] [Abstract][Full Text] [Related]
37. Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data from PREDICTIVE. Dornhorst A; Lüddeke HJ; Koenen C; Meriläinen M; King A; Robinson A; Sreenan S; Diabetes Obes Metab; 2008 Jan; 10(1):75-81. PubMed ID: 18034846 [TBL] [Abstract][Full Text] [Related]
38. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study). Garber AJ; Wahlen J; Wahl T; Bressler P; Braceras R; Allen E; Jain R Diabetes Obes Metab; 2006 Jan; 8(1):58-66. PubMed ID: 16367883 [TBL] [Abstract][Full Text] [Related]
39. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Jeffcoate SL Diabet Med; 2004 Jul; 21(7):657-65. PubMed ID: 15209755 [TBL] [Abstract][Full Text] [Related]
40. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL; Figgitt DP Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]